Online Database of Chemicals from Around the World
(1aR,5S,8S,9S,10R,22aR)-5-(1,1-Dimethylethyl)-9-ethyl-18,18-difluoro-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-14-methoxy-3,6-dioxo-8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxylic acid
[CAS# 1535212-06-6]
Complete supplier list of (1aR,5S,8S,9S,10R,22aR)-5-(1,1-Dimethylethyl)-9-ethyl-18,18-difluoro-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-14-methoxy-3,6-dioxo-8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxylic acid
|
Identification
Name |
(1aR,5S,8S,9S,10R,22aR)-5-(1,1-Dimethylethyl)-9-ethyl-18,18-difluoro-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-14-methoxy-3,6-dioxo-8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxylic acid |
|
Molecular Structure |
![CAS # 1535212-06-6, (1aR,5S,8S,9S,10R,22aR)-5-(1,1-Dimethylethyl)-9-ethyl-18,18-difluoro-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-14-methoxy-3,6-dioxo-8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxylic acid](/structures/1535212-06-6.gif) |
Molecular Formula |
C31H40F2N4O7 |
Molecular Weight |
618.67 |
CAS Registry Number |
1535212-06-6 |
|
Properties
Solubility |
Insoluble (3.0E-4 g/L) (25 ºC), Calc.* |
Density |
1.34±0.1 g/cm3 (20 ºC 760 Torr), Calc.* |
|
*
|
Calculated using Advanced Chemistry Development (ACD/Labs) Software V11.02 (©1994-2016 ACD/Labs)
|
|
Market Analysis Reports |
List of Reports Available for (1aR,5S,8S,9S,10R,22aR)-5-(1,1-Dimethylethyl)-9-ethyl-18,18-difluoro-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-14-methoxy-3,6-dioxo-8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxylic acid
|
|
Related Products
(2R)-3-[[(1,1-Dimethylethyl)diphenylsilyl]oxy]-2,5-dihydro-2-furanmethanol (3aR,4R,6aR)-4-[[(1,1-Dimethylethyl)diphenylsilyl]oxy]-5-fluoro-3a,6a-dihydro-2,2-dimethyl-6-[(triphenylmethoxy)methyl]-4H-cyclopenta-1,3-dioxole (1R,3R,4S)-4-[[(1,1-Dimethylethyl)diphenylsilyl]oxy]-2-methylene-3-[(triphenylmethoxy)methyl]cyclopentanol N-[(1S)-2-[[(1,1-Dimethylethyl)diphenylsilyl]oxy]-1-[(1-methyl-1H-imidazol-5-yl)methyl]ethyl]-2,4,6-tris(1-methylethyl)benzenesulfonamide (3R,4S)-4-[4-[[(1,1-Dimethylethyl)diphenylsilyl]oxy]phenyl]-1-(4-fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-hydroxypropyl]-2-azetidinone 1-O-[(1,1-Dimethylethyl)diphenylsilyl]-3-O-(phenylmethyl)-beta-D-glucopyranuronic acid methyl ester 2-benzoate N,N'-Dimethylethylenediamine (3R,7aR)-3-(1,1-Dimethylethyl)-7a-ethenyldihydro-1H,3H-pyrrolo[1,2-c]oxazole-1,5(6H)-dione (3R,7aR)-3-(1,1-Dimethylethyl)-7a-ethenyltetrahydro-1-hydroxy-3H,5H-pyrrolo[1,2-c]oxazol-5-one (1aR,5S,8S,9S,10R,19E,22aR)-5-(1,1-Dimethylethyl)-9-ethyl-18,18-difluoro-1,1a,3,4,5,6,9,10,18,21,22,22a-dodecahydro-14-methoxy-3,6-dioxo-8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxylic acid 1,1-dimethylethyl ester (1aR,5S,8S,9S,10R,22aR)-5-(1,1-Dimethylethyl)-9-ethyl-18,18-difluoro-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-14-methoxy-3,6-dioxo-8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxylic acid 1,1-dimethylethyl ester O-(1,1-Dimethylethyl)-N-[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]-D-threonine 1-(1,1-Dimethylethyl)-3-ethyl-5-methylcyclohexane O-(1,1-Dimethylethyl)-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-N-methyl-D-serine 4-(1,1-Dimethylethyl)-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-D-phenylalanine 1,1-Dimethylethyl 6-fluoro-2,3-dihydro-1H-indole-1-carboxylate N-(1,1-Dimethylethyl)-N'-[3-[[5-fluoro-4-[(2-hydroxy-1,1-dimethylethyl)amino]-2-pyrimidinyl]amino]phenyl]urea 5-[2-(1,1-Dimethylethyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl]-3-(2,2-dimethylpropyl)-3H-imidazo[4,5-b]pyridin-2-amine 3-(1,1-Dimethylethyl)-7-[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyridine 1,1-Dimethylethyl 6-formyl-2,2-dimethyl-1,3-dioxane-4-acetate